Nicotinamide Adenine Dinucleotide Market Size - By Grade (Food grade, Pharmaceutical grade), By Application (Dietary supplements, Pharmaceuticals, Anti-aging Products) & Global Forecast, 2022 - 2030

Nicotinamide Adenine Dinucleotide Market Size

Nicotinamide Adenine Dinucleotide Market size was recorded at over USD 488 million in 2021. Driven by changing lifestyle choices, the industry is expected to grow at around 13% CAGR from 2022 to 2030.
 

Nicotinamide adenine dinucleotide or NAD is attaining positive attention due to its varied health benefits, such as improving athletic performance, reducing chronic fatigue syndrome, managing high cholesterol, treating depression, controlling high blood pressure, helping in anti-aging, maintaining the effects of alcohol on the liver, and more. Mounting utilization and demand from pharmaceuticals are likely to foster nicotinamide adenine dinucleotide market growth over 2022-2030.
 

Consistent R&D initiatives to improve the effectiveness of NADH or NAD+ on the metabolism to offer therapeutic intervention in inflammatory disorders are contributing substantially to the product adoption rate. For instance, a May 2022 study on NAD metabolism in the immune response, autoimmunity, and inflammageing, funded by the Spanish Ministry of Science and Innovation, concluded that stimuli timing, dosage, and the cellular metabolic state, together with the form of NAD+ supplementation result in the increased global level of NAD+.
 

Government regulations on dosage may restrain industry progression

Stringent government norms regarding dosage to prevent adverse health effects are foreseen to restrain industry expansion. As NAD works differently depending on the dosage and therapy, the government agencies of various countries have only given it OTC categorization. Nonetheless, advancements in food grade NAD in the form of immunity boosters are set to proliferate the demand for nicotinamide adenine dinucleotide supplements, thereby enabling companies to overcome this issue.
 

Nicotinamide Adenine Dinucleotide Market Analysis

In terms of grade, nicotinamide adenine dinucleotide market is categorized into food grade pharmaceutical grade, and others. The pharmaceutical grade is expected to surpass USD 515 million in revenue by 2030 as a result of numerous benefits of the product as an anti-depressant, an anti-aging solution, and for improving cell restoration, bolstering the inclusion of NADH in many disease-curing drugs, thereby stimulating the demand for the pharmaceutical grade of the nicotinamide adenine dinucleotide globally.
 

In terms of application, nicotinamide adenine dinucleotide market is segregated into dietary supplements, pharmaceuticals, anti-aging products, and others. Anti-aging products segment was valued at more than USD 110 million in 2021 and is estimated to progress at 14.5% CAGR over the next 8 years as NAD+ anti-aging products are used to treat rosacea, pigmentation, fine lines, wrinkles, and acne. The rising popularity of skincare and cosmetics products, along with the surging awareness of the advantages of NAD supplements.
 

Nicotinamide adenine dinucleotide market is segmented into Europe, Asia Pacific, North America, the Middle East & Africa, and Latin America. The Europe NAD market is anticipated to reach over USD 330 million in revenue by 2030. The surging consumer interest in anti-aging products containing nicotinamide adenine dinucleotide in is propelling regional market demand. In addition, the strong presence of pharmaceutical manufacturers that are providing advanced functional beverage products is speculated to augment the regional industry expansion.
 

Nicotinamide Adenine Dinucleotide Market Share

• Bontac Bioengineering
• Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
• F. Hoffmann-La Roche Ltd
• HiMedia Laboratories
• NutriScience Innovations, LLC
• Nutrifoods
• Bontac Bio-engineering(shenzhen)co.,ltd
• Krackeler Scientific
• Shandong Lankang Bio-Technology Co., Ltd.
• OYC Americas, Inc.
• Xi'an Yinherb Bio-Tech Co., Ltd
• Shenzhen Hygieia Biotechnology Co., Ltd
• Zhejiang Dazhan Biotechnology Co., Ltd.
• Otto Chemie Pvt. Ltd.
• Uthever

are some of the key nicotinamide adenine dinucleotide market players. These companies are adopting strategic mergers, collaborations, and acquisitions to expand their customer base and improve their product offerings.
 

Impact of COVID-19 Pandemic

The nicotinamide adenine dinucleotide industry witnessed an upsurge in demand during the COVID-19 pandemic as coronavirus resulted in the dysregulation of genes related to NAD+ metabolism. For instance, a 2022 study found that NAD+ and NMN supplements that were used to treat pneumonia phenotypes, consisting of hemolysis, excessive inflammatory cell infiltration, and embolization, in SARS-CoV-2-infected lungs were effectively liberated. Moreover, in the post-pandemic scenario, many companies are engaging in securing and sustaining their supply networks to fulfill the global demand for NAD, which is driving industry expansion in key regions worldwide.
 

The nicotinamide adenine dinucleotide market research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in tons and revenue in USD Mn from 2017 to 2030 for the following segments:

Click here to Buy Section of this Report

By Grade

• Food Grade
• Pharmaceutical Grade
• Others

By Application

• Dietary Supplements
• Pharmaceuticals
• Anti-aging Products
• Others

The above information is provided on a regional and country basis for the following:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Argentina
  • Mexico
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa